Developer docs
API playgroundTry for free, no card

Search company profiles

Nosch

Full company profile

uuid002lpaz

Namestring
Nosch
Websiteurl
noschlabs.net
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Nosch is a privately held, for-profit pharmaceutical manufacturer based in Kukatpally (Hyderabad), India, operating with an 11–50 employee headcount. The company manufactures active pharmaceutical ingredients (APIs) and semi-finished formulations, positioning it within India's mid-tier pharma manufacturing cluster that typically serves domestic generic formulators and, where regulatory approvals permit, international buyers.

The company's product scope — APIs and semi-finished formulations — places it upstream of finished-dose manufacturers. Semi-finished formulations (intermediates requiring further processing) and APIs serve as inputs to formulation companies producing tablets, capsules, injectables, or other finished dosages. The firm's location in Kukatpally, a known Hyderabad pharma hub, is consistent with the regional concentration of Indian API and intermediate manufacturers that leverage local chemistry talent and established supply-chain infrastructure.

Public disclosures are minimal: the company's website (noschlabs.net) currently returns only a verification/waiting page rather than substantive product, certification, or leadership content. No customer logos, pricing, partnerships, certifications (GMP/USFDA/EDQM), management team, funding history, or revenue figures are documented in the available source material. As a result, the business model mechanics — whether revenue is generated through B2B bulk API supply, contract manufacturing, toll processing, or branded intermediate sales — cannot be determined from the available evidence, and the company should be treated as an opaque sub-50-employee private pharma manufacturer pending further disclosure.

Short descriptiontext

Nosch is an India-based pharmaceutical manufacturer in Kukatpally (Hyderabad) producing active pharmaceutical ingredients and semi-finished formulations, serving as a supplier to formulation companies in the pharma supply chain.

Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
active pharmaceutical ingredients, API manufacturing, pharmaceutical formulations, bulk drug manufacturing, intermediate formulations
Industry4 codes
PRIMARYHLAGAHAB
Small-Molecule API Commercial Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAIABAG
Generic APIs & Intermediates (Active Ingredients)
SECONDARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code3 codes
  • Medicinal and Botanical Manufacturing325411
  • Pharmaceutical and Medicine Manufacturing3254
  • Pharmaceutical Preparation Manufacturing325412
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Industrial Organic Chemicals2860
Product category
Active Pharmaceutical Ingredient Manufacturing
Social media profiles1 record
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Nosch manufactures active pharmaceutical ingredients (APIs) and semi-finished formulations. The company operates as a pharmaceutical manufacturer producing bulk drug substances and intermediate dosage forms for downstream pharmaceutical use.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Active Pharmaceutical Ingredients (APIs)
CategoryActive Pharmaceutical Ingredients
Description

Bulk drug substances manufactured by Nosch and supplied to pharmaceutical formulators for use in finished dosage form production.

2Semi-finished Pharmaceutical Formulations
CategoryPharmaceutical Formulations
Description

Intermediate dosage forms produced by Nosch that serve as inputs for further pharmaceutical manufacturing.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CDMO and API manufacturer with India-based operations serving innovator pharma across small molecules. Comparable to Nosch in API manufacturing services and formulation-intermediate offerings.

TypeDirect peer
Description

Indian manufacturer of APIs and intermediates, supplying global generic and innovator companies. Comparable to Nosch in API manufacturing focus, scale tier, and target customer segments.

TypeBroad incumbent
Description

Major Indian pharma company with significant API manufacturing operations plus finished formulations. Comparable to Nosch in combining API and formulation manufacturing, though at vastly larger scale and global commercialization.

TypeDirect peer
Description

India-based API and CDMO business formed from carve-outs of established API operations. Directly comparable to Nosch in API manufacturing services and semi-finished intermediates supply to global pharma.

TypeDirect peer
Description

Indian CDMO and API manufacturer specializing in small-molecule APIs and intermediates for global innovator and generic pharma. Comparable to Nosch in offering API manufacturing with formulation-intermediate exposure.

TypeDirect peer
Description

India-based API and intermediate manufacturer serving regulated markets, with focus on small-molecule process chemistry and contract manufacturing. Directly comparable to Nosch in API manufacturing focus and customer profile.

TypeDirect peer
Description

One of India's largest API manufacturers, producing both small-molecule APIs and intermediates for global pharma. Closely comparable to Nosch in the API and intermediate manufacturing value chain, though at much larger scale.

TypeDirect peer
Description

Smaller India-based API manufacturer focused on niche small-molecule APIs. Comparable to Nosch as a similarly scaled Indian API specialist with overlapping customer profiles in semi-regulated markets.

TypeBroad incumbent
Description

Vertically integrated Indian pharma manufacturer with large-scale API operations plus finished formulations. Comparable to Nosch's dual API and semi-finished formulation positioning, but with global commercial reach and extensive regulatory filings.

TypeDirect peer
Description

Indian pharma manufacturer with integrated API production and finished dosage formulations including semi-finished dosages. Comparable to Nosch in its vertical integration from APIs into formulations.

Market position
Strengths3 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat1 record

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights3 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nosch

Active Pharmaceutical Ingredient Manufacturingnoschlabs.net

Nosch is an India-based pharmaceutical manufacturer in Kukatpally (Hyderabad) producing active pharmaceutical ingredients and semi-finished formulations, serving as a supplier to formulation companies in the pharma supply chain.

What Nosch does

Nosch is a privately held, for-profit pharmaceutical manufacturer based in Kukatpally (Hyderabad), India, operating with an 11–50 employee headcount. The company manufactures active pharmaceutical ingredients (APIs) and semi-finished formulations, positioning it within India's mid-tier pharma manufacturing cluster that typically serves domestic generic formulators and, where regulatory approvals permit, international buyers.

The company's product scope — APIs and semi-finished formulations — places it upstream of finished-dose manufacturers. Semi-finished formulations (intermediates requiring further processing) and APIs serve as inputs to formulation companies producing tablets, capsules, injectables, or other finished dosages. The firm's location in Kukatpally, a known Hyderabad pharma hub, is consistent with the regional concentration of Indian API and intermediate manufacturers that leverage local chemistry talent and established supply-chain infrastructure.

Public disclosures are minimal: the company's website (noschlabs.net) currently returns only a verification/waiting page rather than substantive product, certification, or leadership content. No customer logos, pricing, partnerships, certifications (GMP/USFDA/EDQM), management team, funding history, or revenue figures are documented in the available source material. As a result, the business model mechanics — whether revenue is generated through B2B bulk API supply, contract manufacturing, toll processing, or branded intermediate sales — cannot be determined from the available evidence, and the company should be treated as an opaque sub-50-employee private pharma manufacturer pending further disclosure.

Nosch firmographics

Firmographics
Name
Nosch
Website
https://noschlabs.net
Company type
Private
Headcount range
11–50 employees
Short description
Nosch is an India-based pharmaceutical manufacturer in Kukatpally (Hyderabad) producing active pharmaceutical ingredients and semi-finished formulations, serving as a supplier to formulation companies in the pharma supply chain.
Ownership category
akta.pro rank

Nosch industry classification

Industry
Product category
Active Pharmaceutical Ingredient Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
SIC
Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
akta.pro industry
PRIMARYHLAGAHAB
Small-Molecule API Commercial Manufacturing
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAIABAG
Generic APIs & Intermediates (Active Ingredients)
SECONDARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAM
Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • Active pharmaceutical ingredients
  • API manufacturing
  • Pharmaceutical formulations
  • Bulk drug manufacturing
  • Intermediate formulations

Where Nosch is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Markets served

Nosch business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Nosch product offering

Product offering

Core offering

Nosch manufactures active pharmaceutical ingredients (APIs) and semi-finished formulations. The company operates as a pharmaceutical manufacturer producing bulk drug substances and intermediate dosage forms for downstream pharmaceutical use.

Differentiator

Problem solved

Functional benefit

Products and services

  • Active Pharmaceutical Ingredients (APIs) Bulk drug substances manufactured by Nosch and supplied to pharmaceutical formulators for use in finished dosage form production.
  • Semi-finished Pharmaceutical Formulations Intermediate dosage forms produced by Nosch that serve as inputs for further pharmaceutical manufacturing.

Companies that use Nosch

Customer profile

Ideal customer profiles1 record

Nosch technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Nosch partnerships and signals

Strategic signal

Recent moves1 record

Expansion highlights1 record

Nosch competitors and assessment

Company assessment

Broad incumbents

  • Piramal Pharma Solutions: Global CDMO and API manufacturer with India-based operations serving innovator pharma across small molecules. Comparable to Nosch in API manufacturing services and formulation-intermediate offerings.
  • Dr. Reddy's Laboratories: Major Indian pharma company with significant API manufacturing operations plus finished formulations. Comparable to Nosch in combining API and formulation manufacturing, though at vastly larger scale and global commercialization.
  • Aurobindo Pharma: Vertically integrated Indian pharma manufacturer with large-scale API operations plus finished formulations. Comparable to Nosch's dual API and semi-finished formulation positioning, but with global commercial reach and extensive regulatory filings.

Direct peers

  • SMS Pharmaceuticals: Indian manufacturer of APIs and intermediates, supplying global generic and innovator companies. Comparable to Nosch in API manufacturing focus, scale tier, and target customer segments.
  • Cohance Lifesciences: India-based API and CDMO business formed from carve-outs of established API operations. Directly comparable to Nosch in API manufacturing services and semi-finished intermediates supply to global pharma.
  • Suven Pharmaceuticals: Indian CDMO and API manufacturer specializing in small-molecule APIs and intermediates for global innovator and generic pharma. Comparable to Nosch in offering API manufacturing with formulation-intermediate exposure.
  • Neuland Laboratories: India-based API and intermediate manufacturer serving regulated markets, with focus on small-molecule process chemistry and contract manufacturing. Directly comparable to Nosch in API manufacturing focus and customer profile.
  • Divis Laboratories: One of India's largest API manufacturers, producing both small-molecule APIs and intermediates for global pharma. Closely comparable to Nosch in the API and intermediate manufacturing value chain, though at much larger scale.
  • CTX Lifesciences: Smaller India-based API manufacturer focused on niche small-molecule APIs. Comparable to Nosch as a similarly scaled Indian API specialist with overlapping customer profiles in semi-regulated markets.
  • Granules India: Indian pharma manufacturer with integrated API production and finished dosage formulations including semi-finished dosages. Comparable to Nosch in its vertical integration from APIs into formulations.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

Nosch social profiles

Digital presence

Nosch financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nosch leadership team

Management profile

Number of profiles

Nosch funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nosch M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nosch

What does Nosch do?

Nosch manufactures active pharmaceutical ingredients (APIs) and semi-finished formulations. The company operates as a pharmaceutical manufacturer producing bulk drug substances and intermediate dosage forms for downstream pharmaceutical use.

When was Nosch founded?

Nosch was founded in -1. It employs 11 to 50 people.

Where is Nosch based?

Nosch is headquartered in Hyderabad, India, in the Asia region.

Who are Nosch's main competitors?

Broad incumbents on record are Piramal Pharma Solutions, Dr. Reddy's Laboratories and Aurobindo Pharma. Direct peers are SMS Pharmaceuticals, Cohance Lifesciences, Suven Pharmaceuticals, Neuland Laboratories, Divis Laboratories, CTX Lifesciences and Granules India.

Does Nosch have an API?

No public API is recorded for Nosch.

What industry is Nosch in?

Nosch's product category is Active Pharmaceutical Ingredient Manufacturing. Its primary akta.pro industry code is HLAGAHAB, Small-Molecule API Commercial Manufacturing, with a secondary code of HLAIABAG, Generic APIs & Intermediates (Active Ingredients). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales